BTK is a central contributor to B-cell lymphoma pathogenesis, as it is significantly more active (increased phosphorylation) in B-cell lymphomas than in normal B-cells [6]. The gene discussed is BTK; the disease is B-cell non-Hodgkin lymphoma.